ARCHIVES

Q & A: NCI’s Doroshow Says Phase I Program Will Stress Correlative Studies for Small Biotech Firms

This article is from The Cancer Letter archive.

Vol. 38 No. 14 | April 6, 2012

Download PDF Visit The Full Archive

Related Articles

Cancer Meetings Listed

October 24, 1997

First shakeup In Upton Regime: Peters Moves Out As DCCP Head To Become “Special Assistant”

September 30, 1977

In Brief: Hohn Named President, CEO Of Roswell Park; Mendelsohn Honored; AACE Elects Officers

February 7, 1997

Abstracts of Papers From ASCO Meeting

April 14, 1978

White House Announces FDA Initiatives To accelerate Cancer Drug Approval

April 4, 1996

Private Sector Still Valuable To National Cancer Program, ACS Research Chief Says

April 26, 1974